The importance of an independent validation cohort for metabolomics biomarker studies

Jean-Pierre Trezzi^{1

2}, Karsten Hiller^{3

4}, Brit Mollenhauer⁵

Affiliations

¹ Integrated Biobank of Luxembourg, Dudelange, Luxembourg.
² Luxembourg Center for Systems Biomedicine, avenue de l'Université, Esch-sur-Alzette, Luxembourg.
³ Braunschweig Integrated Centre for Systems Biology (BRICS), Technische Universität Braunschweig, Germany.
⁴ Helmholtz Centre for Infection Research, Braunschweig, Germany.
⁵ Paracelsus-Elena Klinik, Kassel and University Medical Center, Goettingen, Germany.

Comment

Jean-Pierre Trezzi et al. Mov Disord. 2018 May.

. 2018 May;33(5):856.

doi: 10.1002/mds.27374. Epub 2018 May 3.

Jean-Pierre Trezzi^{1

2}, Karsten Hiller^{3

4}, Brit Mollenhauer⁵

¹ Integrated Biobank of Luxembourg, Dudelange, Luxembourg.
² Luxembourg Center for Systems Biomedicine, avenue de l'Université, Esch-sur-Alzette, Luxembourg.
³ Braunschweig Integrated Centre for Systems Biology (BRICS), Technische Universität Braunschweig, Germany.
⁴ Helmholtz Centre for Infection Research, Braunschweig, Germany.
⁵ Paracelsus-Elena Klinik, Kassel and University Medical Center, Goettingen, Germany.

No abstract available

Comment on

Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease.
Trezzi JP, Galozzi S, Jaeger C, Barkovits K, Brockmann K, Maetzler W, Berg D, Marcus K, Betsou F, Hiller K, Mollenhauer B. Trezzi JP, et al. Mov Disord. 2017 Oct;32(10):1401-1408. doi: 10.1002/mds.27132. Epub 2017 Aug 26. Mov Disord. 2017. PMID: 28843022
Comment on 'Distinct Metabolomic Signature in Cerebrospinal Fluid in Early Parkinson's Disease' by Hiller et al.
LeWitt PA. LeWitt PA. Mov Disord. 2018 May;33(5):855. doi: 10.1002/mds.27379. Epub 2018 May 3. Mov Disord. 2018. PMID: 29722456 No abstract available.